(0.33%) 5 116.61 points
(0.32%) 38 361 points
(0.37%) 15 987 points
(-0.97%) $83.04
(5.36%) $2.03
(0.30%) $2 354.30
(0.42%) $27.65
(4.13%) $960.20
(-0.27%) $0.932
(-0.46%) $10.97
(-0.59%) $0.796
(1.66%) $93.40
@ $136.62
発行日: 29 4月 2024 @ 22:30
リターン: -0.27%
前回のシグナル: 4月 27 - 01:07
前回のシグナル:
リターン: 0.79 %
Live Chart Being Loaded With Signals
Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry...
Stats | |
---|---|
本日の出来高 | 141 596 |
平均出来高 | 512 482 |
時価総額 | 7.21B |
EPS | $0 ( 2024-02-27 ) |
次の収益日 | ( $0.710 ) 2024-05-07 |
Last Dividend | $1.000 ( 2012-11-23 ) |
Next Dividend | $0 ( N/A ) |
P/E | 90.23 |
ATR14 | $2.41 (1.77%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-01 | Tripodi Blair | Buy | 30 000 | Restricted Stock Units |
2024-03-01 | Tripodi Blair | Buy | 9 127 | Non-Qualified Stock Option (Right to Buy) |
2024-03-01 | Muhsin Bilal | Buy | 30 000 | Restricted Stock Units |
2024-02-28 | Muhsin Bilal | Buy | 2 010 | Common Stock |
2024-02-28 | Muhsin Bilal | Sell | 745 | Common Stock |
INSIDER POWER |
---|
77.94 |
Last 93 transactions |
Buy: 793 924 | Sell: 148 839 |
ボリューム 相関
Masimo Corp 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Masimo Corp 相関 - 通貨/商品
Masimo Corp 財務諸表
Annual | 2023 |
収益: | $2.05B |
総利益: | $1.00B (49.00 %) |
EPS: | $1.540 |
FY | 2023 |
収益: | $2.05B |
総利益: | $1.00B (49.00 %) |
EPS: | $1.540 |
FY | 2022 |
収益: | $2.04B |
総利益: | $1.06B (52.01 %) |
EPS: | $2.68 |
FY | 2021 |
収益: | $1.24B |
総利益: | $808.35M (65.23 %) |
EPS: | $4.16 |
Financial Reports:
No articles found.
Masimo Corp Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $2.00 | 2010-03-09 |
Last Dividend | $1.000 | 2012-11-23 |
Next Dividend | $0 | N/A |
Payout Date | 2012-12-11 | |
Next Payout Date | N/A | |
# dividends | 3 | -- |
Total Paid Out | $3.75 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 1.91 | -- |
Div. Sustainability Score | 9.50 | |
Div.Growth Potential Score | 1.722 | |
Div. Directional Score | 5.61 | -- |
Year | Amount | Yield |
---|---|---|
2010 | $2.75 | 9.24% |
2011 | $0 | 0.00% |
2012 | $1.000 | 5.31% |
2013 | $0 | 0.00% |
2014 | $0 | 0.00% |
2015 | $0 | 0.00% |
2016 | $0 | 0.00% |
2017 | $0 | 0.00% |
2018 | $0 | 0.00% |
2019 | $0 | 0.00% |
2020 | $0 | 0.00% |
2021 | $0 | 0.00% |
2022 | $0 | 0.00% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0398 | 1.500 | 9.20 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0268 | 1.200 | 9.11 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0618 | 1.500 | -0.425 | -0.637 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 2.18 | 0.800 | 4.08 | 3.26 | [1 - 3] |
quickRatioTTM | 1.041 | 0.800 | 8.58 | 6.87 | [0.8 - 2.5] |
cashRatioTTM | 0.294 | 1.500 | 9.48 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.304 | -1.500 | 4.94 | -7.40 | [0 - 0.6] |
interestCoverageTTM | 3.14 | 1.000 | 9.95 | 9.95 | [3 - 30] |
operatingCashFlowPerShareTTM | 1.782 | 2.00 | 9.41 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.121 | 2.00 | 9.94 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.677 | -1.500 | 7.29 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.490 | 1.000 | 5.17 | 5.17 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0769 | 1.000 | -0.463 | -0.463 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.102 | 1.000 | -0.545 | -0.545 | [0.2 - 2] |
assetTurnoverTTM | 0.673 | 0.800 | 8.84 | 7.08 | [0.5 - 2] |
Total Score | 9.50 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 88.20 | 1.000 | 1.192 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0618 | 2.50 | -0.273 | -0.637 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.121 | 2.00 | 9.96 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 1.782 | 2.00 | 9.41 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.307 | 1.500 | -1.289 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0459 | 1.000 | -1.351 | 0 | [0.1 - 0.5] |
Total Score | 1.722 |
Masimo Corp
Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. It offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, handheld capnograph and capnometer devices, and capnography sampling lines; O3 regional oximetry for tissue oxygen saturation measurement; and hemodynamic monitoring solutions. Its Masimo Hospital Automation platform includes Patient SafetyNet, Patient SafetyNet surveillance, Kite, UniView, Replica, UniView : 60, and MyView. It offers connectivity devices; and nasal high flow ventilation and neuromodulation solutions. It provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and non-medical/consumer products through e-commerce site, masimopersonalhealth.com. The company was incorporated in 1989 and is headquartered in Irvine, California.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。